Value of renal biopsy in the prognosis of liver transplantation in familial amyloid polyneuropathy ATTR Val30Met patients

被引:17
|
作者
Oguchi, Kenya [1 ]
Takei, Yo-Ichi [1 ]
Ikeda, Shu-Ichi [1 ]
机构
[1] Shinshu Univ, Sch Med, Dept Med 3, Matsumoto, Nagano 3908621, Japan
来源
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS | 2006年 / 13卷 / 02期
关键词
amyloid; familial amyloid polyneuropathy; renal amyloidosis; transthyretin; liver transplantation;
D O I
10.1080/13506120600722662
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Liver transplantation for familial amyloid polyneuropathy (FAP) patients has been carried out worldwide and the outcomes seem to be promising. To clarify the severity of amyloid deposits on visceral organs, we evaluated the histopathological findings of biopsied renal and sural nerve specimens in 13 FAP patients with ATTR Va130Met by quantitative analysis, and compared them with the outcome of transplantation. Renal dysfunction with proteinuria seemed to correlate with the degree of amyloid deposits in glomeruli, not with that in medullary tissues. The severity of renal amyloid deposition did not consistently parallel that of myelinated nerve fiber loss in sural nerve. Three patients with proteinuria and severe amyloid deposits in glomeruli were considered to be unsuitable for transplantation. Ten patients underwent living donor liver transplantation and three resulted in unfavorable outcomes. These three had heavy amyloid deposits on renal tissues, especially in glomerular areas, but the severity of myelinated nerve fiber loss in their sural nerves was very similar to that in patients who made a good recovery. The prognosis after operation might be closely related to the severity of amyloid deposits in renal glomeruli. Renal biopsy is, therefore, recommended when determining the indications and contraindications for liver transplantation in FAP patients, although this biopsy is not routinely required.
引用
收藏
页码:99 / 107
页数:9
相关论文
共 50 条
  • [31] Spinal cord stimulation markedly ameliorated refractory neuropathic pain in transthyretin Val30Met familial amyloid polyneuropathy
    Miyazaki, Yu
    Koike, Haruki
    Akane, Akiko
    Shibata, Yasuyuki
    Nishiwaki, Kimitoshi
    Sobue, Gen
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2011, 18 (02): : 87 - 90
  • [32] The Val30Met familial amyloid polyneuropathy specific Rasch-built overall disability scale (FAP-RODS(C))
    Pruppers, Marielle H. J.
    Merkies, Ingemar S. J.
    Faber, Catharina G.
    Da Silva, Ana M.
    Costa, Vanessa
    Coelho, Teresa
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (03) : 319 - 327
  • [33] Familial amyloidotic polyneuropathy type 1 in Brazil is associated with the transthyretin Val30Met variant
    Palácios, SA
    Bittencourt, PL
    Cançado, ELR
    Farias, AQ
    Massarollo, PCB
    Mies, S
    Kalil, J
    Goldberg, AC
    AMYLOID-INTERNATIONAL JOURNAL OF EXPERIMENTAL AND CLINICAL INVESTIGATION, 1999, 6 (04): : 289 - 291
  • [34] Response: concerning "late early and late onset" ATTR Val30Met patients
    Suhr, Ole B.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 (04): : 250 - 250
  • [35] Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy
    Taguchi, Kazuaki
    Jono, Hirofumi
    Kugimiya-Taguchi, Tomoe
    Nagao, Saori
    Su, Yu
    Yamasaki, Keishi
    Mizuguchi, Mineyuki
    Maruyama, Toru
    Ando, Yukio
    Otagiri, Masaki
    LIFE SCIENCES, 2013, 93 (25-26) : 1017 - 1022
  • [36] Macular and optic disc edema and retinal vascular leakage in familial amyloid polyneuropathy with a transthyretin Val30Met mutation: A case report
    Dias-Santos A.
    Ferreira J.
    Cunha J.P.
    Journal of Medical Case Reports, 8 (1)
  • [37] Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation
    Snanoudj, R
    Durrbach, A
    Gauthier, E
    Adams, D
    Samuel, D
    Ferlicot, S
    Bedossa, P
    Prigent, A
    Bismuth, H
    Charpentier, B
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (07) : 1779 - 1785
  • [38] Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area
    Andres, N.
    Poza, J. J.
    Marti Masso, J. F.
    NEUROLOGIA, 2018, 33 (09): : 583 - 589
  • [39] Continuous Development of Arrhythmia Is Observed in Swedish Transplant Patients With Familial Amyloidotic Polyneuropathy (Amyloidogenic Transthyretin Val30Met Variant)
    Okamoto, Sadahisa
    Hoernsten, Rolf
    Obayashi, Konen
    Wijayatunga, Priyantha
    Suhr, Ole B.
    LIVER TRANSPLANTATION, 2011, 17 (02) : 122 - 128
  • [40] Clinical and pathological findings of non-Val30Met TTR type familial amyloid polyneuropathy in Japan
    Ikeda, S
    Takei, Y
    Tokuda, T
    Nakazato, M
    Ando, Y
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2003, 10 : 39 - 47